期刊文献+

厄贝沙坦与苯那普利治疗轻中度原发性高血压的疗效比较 被引量:4

下载PDF
导出
摘要 目的 :比较厄贝沙坦与苯那普利治疗轻中度原发性高血压 (EH)的临床疗效。方法 :将 90例轻中度 EH患者分为厄贝沙坦组 (n=4 5 )和苯那普利组 (n=4 5 ) ,前者给予厄贝沙坦 1 5 0 mg口服 ,qd;后者给予苯那普利 1 0 mg口服 ,qd,疗程 1 2周。治疗前后测偶测血压、动态血压 ,观察不良反应。结果 :厄贝沙坦组总有效率为 77.8% ,降压幅度为 2 2 .6 / 1 4 .4 m m Hg,T/ P比值 :SBP0 .81、DBP0 .80 ;苯那普利组总有效率为 80 % ,降压幅度为 2 2 .9/ 1 4 .6 m m Hg,T/ P比值 :SBP0 .82 ,DBP0 .81。各项指标两组间比较无显著性差异 (P>0 .0 5 )。厄贝沙坦组干咳发生率 (2 .2 % )与苯那普利组 (2 2 .2 % )比较有显著性差异 (P<0 .0 5 )。结论 :厄贝沙坦治疗轻中度 EH有效 ,降压效果与苯那普利相似 。
作者 杨红芳
出处 《广西医学》 CAS 2003年第12期2436-2437,共2页 Guangxi Medical Journal
  • 相关文献

参考文献3

二级参考文献19

  • 1[1]Aceto JF, Baker KM. Angiotensin Ⅱ receptor-midiated stimulation of protein synthesis in chick heart cell[J]. Am J Physiol,1990,258:H806-H813.
  • 2[2]Ibrahim J, Hughes AD, Sever PD. Action of angiotesin Ⅱ on DNA synthesis by human saphenous vein in organ culture[J]. Hypertens,2000,36(5):917-921.
  • 3[3]Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin Ⅱ causes vascular hypertrophy in part by a non-pressor mechanism[J]. Hypertens,1991,17:626-635.
  • 4[4]Su EJ, Lombardi DM, Siegal J, et al. Angiotensin Ⅱ induces vascular smooth muscle cell replication independent of blood pressure[J]. Hypertens,1998,31:1331-1337.
  • 5[5]Junichi Suzuki, Hiroaki Matsubara, Masaya Urakami, et al. Rat angiotensinⅡ(Type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy[J]. Circulation Research, 1993,73(3):439-447.
  • 6[6]Viseslav D, Sim K, George B. Angiotensin receptor blocker use for hypertension treatment in the elderly[J]. Annals of Long-Term care ,1999,7(8):305-308.
  • 7[7]VanKats JP, Duncker DJ, Haitsma DB, et al.Angiotensin-converting enzyme inhibition and angiotensin Ⅱ type 1 receptor blockade prevent cardiac remodeling in pig after myocardial infarction:role of tissue angiotensinⅡ[J]. Circulation,2000,26(9):1556-1563.
  • 8[8]Yayama K, Wang C, Chao L,et al. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in goldblatt hypertensive rat[J]. Hypertens,1998,31:1104-1110.
  • 9[9]Dzau VJ,Re R. Tissue angiotensin system in cardiovascular medicine :a paradigm shift?[J].Circulation,1994,89:493-498.
  • 10[10]Nunez E,Hosoya K,Susic D,et al.Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR[J].Hypertens,1997,29:519-524.

共引文献11

同被引文献33

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部